Morgan Stanley’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$142M Buy
9,972,113
+5,277,645
+112% +$75.4M 0.01% 1090
2025
Q1
$49.3M Buy
4,694,468
+1,157,496
+33% +$12.2M ﹤0.01% 1824
2024
Q4
$42.8M Sell
3,536,972
-807,742
-19% -$9.78M ﹤0.01% 1972
2024
Q3
$63.8M Buy
4,344,714
+915,662
+27% +$13.5M ﹤0.01% 1609
2024
Q2
$49.5M Sell
3,429,052
-1,297,235
-27% -$18.7M ﹤0.01% 1771
2024
Q1
$76.9M Sell
4,726,287
-7,349,697
-61% -$120M 0.01% 1374
2023
Q4
$180M Buy
12,075,984
+7,927,179
+191% +$118M 0.01% 1229
2023
Q3
$46.6M Buy
4,148,805
+287,808
+7% +$3.23M ﹤0.01% 1653
2023
Q2
$38.8M Buy
3,860,997
+267,729
+7% +$2.69M ﹤0.01% 1834
2023
Q1
$33.8M Buy
3,593,268
+178,374
+5% +$1.68M ﹤0.01% 1904
2022
Q4
$41.7M Buy
3,414,894
+356,423
+12% +$4.36M ﹤0.01% 1651
2022
Q3
$38M Sell
3,058,471
-2,852,123
-48% -$35.4M 0.01% 1544
2022
Q2
$116M Buy
5,910,594
+2,520,344
+74% +$49.5M 0.02% 835
2022
Q1
$88.5M Buy
3,390,250
+928,745
+38% +$24.2M 0.01% 941
2021
Q4
$69.9M Buy
2,461,505
+83,712
+4% +$2.38M 0.01% 1135
2021
Q3
$75.8M Sell
2,377,793
-297,376
-11% -$9.48M 0.01% 1006
2021
Q2
$92.8M Sell
2,675,169
-1,625,253
-38% -$56.4M 0.01% 888
2021
Q1
$127M Buy
4,300,422
+3,123,293
+265% +$92M 0.02% 656
2020
Q4
$36.1M Sell
1,177,129
-896,290
-43% -$27.5M 0.01% 1336
2020
Q3
$57.9M Buy
2,073,419
+1,226,456
+145% +$34.3M 0.01% 834
2020
Q2
$18.2M Buy
846,963
+297,481
+54% +$6.38M ﹤0.01% 1484
2020
Q1
$12.3M Buy
549,482
+131,196
+31% +$2.94M ﹤0.01% 1629
2019
Q4
$12.3M Sell
418,286
-8,454,807
-95% -$249M ﹤0.01% 2172
2019
Q3
$236M Sell
8,873,093
-4,146,731
-32% -$110M 0.06% 305
2019
Q2
$440M Buy
13,019,824
+2,034,373
+19% +$68.8M 0.12% 172
2019
Q1
$352M Buy
10,985,451
+2,017,328
+22% +$64.7M 0.1% 209
2018
Q4
$283M Sell
8,968,123
-44,468
-0.5% -$1.4M 0.08% 238
2018
Q3
$314M Buy
+9,012,591
New +$314M 0.08% 252